Main > HEPATOLOGY > Hepatitis B Virus > Infection. Treatment > Telbivudine (LdT)/NRTI > Co.: USA. I (Brand Tablets/Patents)

---

Co.: USA. I (Brand Tablets/Patents)'s subsections
Company
Distributed By:
Manufactured By:
Marketed By:
Patent>Assignees, Claims, No., Etc
Patent>Total USA No.: 4
Patent>UpDate: 01.09.07
Patent>US Expiration: 12.10.2019
Status: Approved
Strength: 600 mg
Structural Name No. 1
Structural Name No. 2
Synthetic Thymidine Nucleoside Anal
TradeMark
UnModified Beta-L-Enantiomer
Web-Site

Co.: USA. I (Brand Tablets/Patents)'s products
This section has no products